About lensar inc - LNSR
LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.
LNSR At a Glance
LENSAR, Inc.
2800 Discovery Drive
Orlando, Florida 32826
| Phone | 1-888-536-7271 | Revenue | 58.44M | |
| Industry | Medical Specialties | Net Income | -34,280,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 9.237% | |
| Fiscal Year-end | 12 / 2026 | Employees | 150 | |
| View SEC Filings |
LNSR Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 2.38 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -6.855 |
| Enterprise Value to Sales | 2.355 |
| Total Debt to Enterprise Value | 0.02 |
LNSR Efficiency
| Revenue/Employee | 389,566.667 |
| Income Per Employee | -228,533.333 |
| Receivables Turnover | 8.758 |
| Total Asset Turnover | 0.849 |
LNSR Liquidity
| Current Ratio | 1.153 |
| Quick Ratio | 0.622 |
| Cash Ratio | 0.443 |
LNSR Profitability
| Gross Margin | 44.838 |
| Operating Margin | -42.06 |
| Pretax Margin | -58.663 |
| Net Margin | -58.663 |
| Return on Assets | -49.78 |
| Return on Equity | -1,069.412 |
| Return on Total Capital | 360.842 |
| Return on Invested Capital | -653.637 |
LNSR Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | -28.789 |
| Total Debt to Total Assets | 3.829 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | -20.926 |